Product Program year 2019 Source: CMS Open Payments

No Product Discussed

Drug

Open in the dashboard

General payments

$5,817,705

4,917 payments

Research payments

$16,316,280

193 payments

Through program year 2019, $5,817,705 in general payments and $16,316,280 in research payments were reported against No Product Discussed.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $5,817,705 4,917
2019 Research $16,316,280 193

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $2,671,588 1,413 payments
  2. Sanofi-Aventis U.S. LLC $1,624,453 941 payments
  3. Sanofi US Services Inc. $818,641 491 payments
  4. Sanofi Pasteur Inc. $513,663 1,910 payments
  5. Bioverativ Therapeutics Inc. $189,336 161 payments
  6. Vaxserve Inc. $25 1 payment
Top recipients General payments · program year 2019
  1. Rush University Medical Center Teaching hospital · IL $415,995 7% · 8 payments
  2. The Childrens Hospital Of Philadelp Teaching hospital · PA $259,678 4% · 12 payments
  3. Uci Medical Center Teaching hospital · CA $254,060 4% · 5 payments
  4. Brigham And Womens Hospital Teaching hospital · MA $162,580 3% · 4 payments
  5. Resnick Neuropsychiatric Hospital At Teaching hospital · CA $149,500 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $412,039 13% · 95 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $367,682 11% · 70 practitioners
  3. Internal Medicine $256,201 8% · 368 practitioners
  4. Rheumatology Internal Medicine $150,498 5% · 18 practitioners
  5. Cardiovascular Disease Internal Medicine $142,888 4% · 51 practitioners

The top 5 of 99 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $898,840 15% · 500 recipients
  2. Massachusetts $756,920 13% · 110 recipients
  3. Illinois $706,511 12% · 83 recipients
  4. Pennsylvania $623,915 11% · 139 recipients
  5. New York $309,074 5% · 124 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

4,917 general · 193 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record